NRSN   $1.36  1.49% Market Open

Neurosense Therapeutics Ltd
Total Cash 735.00K
totalCashPerShare 0.047
EBITDA -12.03M
Total Debt 55.00K
quickRatio 0.255
currentRatio 0.263
Total Revenue
debtToEquity
Revenue/Share
ROA -2.22165
ROE
grossProfits
freeCashflow
operatingCashflow
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 20.36M
forwardPE -1.9714286
floatShares 10.35M
sharesOutstanding 19.47M
sharesShort 470.70K
sharesShortPriorMonth 80.55K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.25%
heldPercentInstitutions 0.09%
Short Ratio help_outline 1.06%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue -0.449
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -12.59M
trailingEps -0.93%
forwardEps -0.70%
enterpriseToEbitda -1.69
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.2 2Q 2024
institutionsCount 7
lastUpdated Sept. 16, 2024, 9:56 p.m.